Biotech News

MIMEDX Announces Restructuring and Cost Reduction Initiative

MiMedx (MDXG)MiMedxCompany update

Company Expects to Realize Annualized Savings of Approximately $40 Million MARIETTA, Ga., April 16, 2026 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced a series of cost reduction initiatives intended to prioritize growth opportunities, streamline

Related news

MiMedx

Placental Tissue Products MIMEDX develops and commercializes placental-tissue products for wound care, burns and surgery. Its processing and product portfolio are designed to provide extracellular-matrix and biologic materials that support healing and tissue repair. Wound-Care Portfolio The company has more than a decade of experience...

Recent company news

Stock data

Close
4.33 USD
Market cap
531.74M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States